{"version":"1.0","type":"link","title":"Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors.","author_name":"Poli I 외","author_url":"https://prs-insight.online/author/Poli%20I","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/82202","thumbnail_width":1200,"thumbnail_height":630}